Navigation Links
LSUHSC awarded multi-million dollar grant to reduce pneumonia
Date:1/7/2010

New Orleans, LA Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to further his work on a discovery that plays a critical role in the body's defense against pneumonia.

Bacterial pneumonia is an important clinical problem and defense mechanisms against it are not fully understood. Dr. Kolls and his research team have identified a unique group of white blood cells that play a critical role in defense against pneumonia. These cells rapidly produce two new cytokines (small proteins in the immune system that affect how cells communicate and function) to increase resistance to infection in the lung. The first is interleukin-17 which helps recruit white blood cells into the sight of infection. The second is interleukin-22 which increases the barrier function of the epithelium (tissue lining the lungs). The research funded under this grant will use genetically engineered mice to see which cells need to receive these cytokine signals. Specifically, the researchers will investigate the role of the lung epithelium itself as the primary recipient of these signals. This application will also explore how these cells are generated and how they control infection defense in the lung.

"This work will help advance prevention and treatment of pneumonia and also advance vaccine development against lung infections," said Dr. Kolls. "It will also have broader application because mucous tissues like the lung are also the primary sites of emerging infections such as H1N1 influenza and MRSA (Methicillin-Resistant Staphylococcus aureus)."

According to the Centers for Disease Control and Prevention, in 2006, 1.2 million people in the U.S. were hospitalized with pneumonia and 55,477 people died from the disease.

Globally, pneumonia kills more than 4 million people every year half of these deaths occur among children less than 5 years of age. This is greater than the number of deaths from any other infectious disease, such as AIDS, malaria or tuberculosis. The CDC also reports that recent data show that Americans visit the doctor approximately 12 million times each year to get checked for suspected Staph or MRSA skin infection.

A study of the first population-based nationwide estimates of the burden of invasive MSRA disease from active cases published in 2007 found the incidence in 2005 was 31.8 cases per 100,000 persons, with a mortality rate of about 20%.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related biology news :

1. LSUHSCs England plays key role in developing new ALS treatment guidelines
2. LSUHSC researchers working to prevent diabetic neuropathy
3. Grant supports LSUHSC research on how like cell receptor systems determine very different functions
4. LSUHSC shows for first time infant inhalation of ultrafine air pollution linked to adult lung disease
5. LSUHSCs Bazan awarded ARRA grant to preserve vision
6. LSUHSC research helps link schizophrenia to specific DNA region
7. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
8. LSUHSC research describes function of key protein in cancer spread
9. LSUHSC public health researcher finds reason for weight gain
10. LSUHSC student awarded top national honor for diabetes research
11. LSUHSC research identifies key contributor to Alzheimers disease process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):
(Date:7/25/2017)... ... July 25, 2017 , ... ... of Strategic Planning. His extensive background in consulting, development and marketing make ... marketing and differentiation consulting, business strategy development, new product marketing and global ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... announced that the stock market news outlet had initiated coverage on Interpace ... that screens and identifies exposure, progression and risk analysis from specific cancers ...
(Date:7/20/2017)... ... July 20, 2017 , ... VIC Technology Venture Development™ (VIC™), ... of directors. This addition continues to strengthen and diversify VIC’s board. , "We ... Chairman. “He is a highly accomplished business executive with a broad range of experience ...
(Date:7/18/2017)... ... July 18, 2017 , ... Nanomedical Diagnostics, a ... announces the launch of a new NTA biosensor chip for use with its ... the kinetics of polyhistidine-tagged (His-tagged) molecules quickly and reliably. , “Recombinant proteins ...
Breaking Biology Technology: